Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands

被引:108
作者
Wei, Dong-Qing
Du, Qi-Shi [1 ]
Sun, Hao
Chou, Kuo-Chen
机构
[1] Tianjin Normal Univ, Inst Bioinformat & Drug Discoveries, Tianjin 300074, Peoples R China
[2] Shanghai Jiao Tong Univ, Coll Life Sci & Technol, Shanghai 200240, Peoples R China
[3] Hainan Normal Univ, Dept Chem, Hainan 571158, Peoples R China
[4] Gordon Life Sci Inst, San Diego, CA 92130 USA
基金
中国国家自然科学基金;
关键词
H5N1; avian influenza; bird flu; drug-resistance; neuraminidase; DANA; structure-active relationship; structural bioinformatics; hydrophilic pocket; lipophilic pocket;
D O I
10.1016/j.bbrc.2006.03.210
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The highly pathogenic H5N1 influenza virus, which is rapidly mutating and becoming increasingly drug-resistant, was investigated by means of structure-activity relationship between NA (neuraminidase) and three inhibitors, i.e., DANA (2,3-didehydro-2-deoxy-N-acetyl-neuraminic acid), zanamivir, and oseltamivir. A homology model of the H5N1-NA from the highly pathogenic chicken H5N-1A viruses isolated during the 2003-2004 influenza outbreaks in Japan was built based on the crystal structure of N9-NA complexed with DANA (PDB code: 1F813). It was found that the traditional constituent residues around the active site of NA family are highly conserved in the H5N1-NA. However, a partially lipophilic pocket composed by Ala248 and Thr249 in N9-NA becomes a hydrophilic pocket because the two residues in the H5N1-NA are replaced by hydrophilic residues Ser227 and Asn228, respectively. On the other hand, two hydrophilic residues Asn347 and Asn348 in the N9-NA are replaced by two lipophilic residues Ala323 and Tyr324 in the H5N1-NA, respectively, leading to the formation of a new lipophilic pocket. This kind of subtle variation not only destroys the original lipophilic environment but also changes the complement interaction between the H5N1-NA and DANA. Such a finding might provide insights into the secret why some of H5N1 strains bear high resistance for existing NA inhibitors, and stimulate new strategies for designing new drugs against these viruses. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1048 / 1055
页数:8
相关论文
共 50 条
[1]   DISTRIBUTION OF SEQUENCE DIFFERENCES IN INFLUENZA N9 NEURAMINIDASE OF TERN AND WHALE VIRUSES AND CRYSTALLIZATION OF THE WHALE NEURAMINIDASE COMPLEXED WITH ANTIBODIES [J].
AIR, GM ;
WEBSTER, RG ;
COLMAN, PM ;
LAVER, WG .
VIROLOGY, 1987, 160 (02) :346-&
[2]  
BELPAIRE FM, 1996, PRACTICE MED CHEM FA, P596
[3]   Post-translational processing of β-secretase (β-amyloid-converting enzyme) and its ectodomain shedding -: The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-β production [J].
Benjannet, S ;
Elagoz, A ;
Wickham, L ;
Mamarbachi, M ;
Munzer, JS ;
Basak, A ;
Lazure, C ;
Cromlish, JA ;
Sisodia, S ;
Checler, F ;
Chrétien, M ;
Seidah, NG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :10879-10887
[4]   KNOWLEDGE-BASED PREDICTION OF PROTEIN STRUCTURES AND THE DESIGN OF NOVEL MOLECULES [J].
BLUNDELL, TL ;
SIBANDA, BL ;
STERNBERG, MJE ;
THORNTON, JM .
NATURE, 1987, 326 (6111) :347-352
[5]   Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment [J].
Chou, JJ ;
Matsuo, H ;
Duan, H ;
Wagner, G .
CELL, 1998, 94 (02) :171-180
[6]   Modeling the tertiary structure of human cathepsin-E [J].
Chou, KC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (01) :56-60
[7]   Molecular therapeutic target for type-2 diabetes [J].
Chou, KC .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (06) :1284-1288
[8]   Insights from modeling three-dimensional structures of the human potassium and sodium channels [J].
Chou, KC .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (04) :856-861
[9]   Insights from modeling the tertiary structure of human BACE2 [J].
Chou, KC .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (05) :1069-1072
[10]   Structural bioinformatics and its impact to biomedical science [J].
Chou, KC .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (16) :2105-2134